1. ALLA AKTIER
  2. NYHETER
  3. BRAINCOOL

BrainCool

Nyheter BrainCool Nyheter alla bolag

BrainCool AB (publ): Publication of BrainCool AB's Interim report for Q2 will be brought forward to today, August 28, 2023.

MARKN.

Publication of BrainCool AB's report for the second quarter will be brought forward to today, August 28, 2023. The previously announced date for publication was August 31, 2023.
 
The reason why the company brings forward the financial report is that the report became ready earlier as a result of the targeted new share issue that was decided on earlier today.

Contacts
For more information
Martin Waleij - CEO
+46 - 733 -93 70 76
E-mail: martin.waleij@braincool.se         

About Us
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.
Eminova Fondkommission AB is the company’s Certified Adviser.

Attachments
BrainCool AB (publ): Publication of BrainCool AB's Interim report for Q2 will be brought forward to today, August 28, 2023.

Datum 2023-08-28, kl 08:30
Källa MFN
Bifogade filer
BrainCool AB (publ): Publication of BrainCool AB's Interim report for Q2 will be brought forward to today, August 28, 2023.
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!